Klaus Orlinger

Chief Scientific Officer @ VALANX Biotech

About

I am an experienced R&D executive with long-standing history in pharmaceutical product development, leading research teams and operating cross functionally. I carried multiple drug candidates in the fields of immunooncology and infectious diseases from early research to phase I/II studies in the US and EU. As an empathetic and people-focused leader, I have a proven track record in jointly building a biotech company, taking it from the early conceptual phase to clinical stage, and from seed funding to IPO. I have set up and managed various departments in the US and EU. As an executive leadership member, I contribute to strategic development, establish partnerships in research and with pharma, and communicate with investors. I aspire for excellence in data-driven science and operations, and am passionate about building and leading diverse, cohesive teams with the ultimate goal of delivering new medicines to patients.

Country

Austria

City

Vienna

Industry

Biotechnology

Skill

Technologieentwicklung, Talententwicklung, Strategie, Präsentationen, Stakeholder-Management, Development strategy, Strategic communication, Leadership, Oncology, Immunotherapy, Global Cross-Functional Team Leadership, Strategic thinking, Presentation skills, Pre-clinical Development, Pipeline-Entwicklung, Interpersonal skills, Communication skills, Strategic Planning, Biomarker, Companion Diagnostics

Experience

Chief Scientific Officer

VALANX Biotech

2025-8 - Present · 1 yr 2 mos

Chief Scientific Officer

HOOKIPA Pharma Inc.

2022-1 - 2025-5 · 3 yrs 5 mos

Wien, Österreich

Executive Vice President Research

HOOKIPA Pharma Inc.

2020-3 - 2021-12 · 1 yr 10 mos

Wien, Österreich

• Responsible for Virology and Preclinical, translational and clinical Biomarker Departments • Responsible for generation and characterization of prophylactic and therapeutic vaccines/immunotherapy candidates. • Responsible for internal and external preclinical development from research until and including regulatory filings • Responsible for clinical biomarker readout and translational science • Responsible for initiation and coordination of international research collaborations with partners from pharmaceutical, biotech industry and academia • Representing Research and Preclinical Departments in project team meetings and meetings with executives and investors

Senior Vice President Research

HOOKIPA Pharma Inc.

2019-1 - 2020-3 · 1 yr 3 mos

Wien, Österreich

-Responsible for Virology and Preclinical R&D Departments -Responsible for generation and characterization of prophylactic and therapeutic vaccines/immunotherapy candidates. -Responsible for internal and external preclinical development from research until and including regulatory filings -Responsible for initiation and coordination of international research collaborations with partners from pharmaceutical, biotech industry and academia - Representing Research and Preclinical Departments in project team meetings and meetings with executives and investors

VP Research

HOOKIPA Pharma Inc.

2017-1 - 2019-1 · 2 yrs 1 mo

Wien, Österreich

-R&D on vaccine design. -Project lead on pipeline projects -Project lead on Immunotherapy projects -Lead generation and in vitro analytics of vaccine seed viruses and preclinical evaluation of vaccine candidates. -Initiate supervise research collaborations

Head of Virology

HOOKIPA Pharma Inc.

2012-2 - 2016-12 · 4 yrs 11 mos

Wien, Österreich

-R&D on vaccine design. -Project lead on pipeline projects -Lead generation and in vitro analytics of vaccine seed viruses and preclinical evaluation of vaccine candidates. -Contribution to clinical trail application of HOOKIPAs lead vaccine indication